Clinical Trial Update: ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder [NA]

View source ↗

Summary

A completed clinical trial evaluating ERP N1 as a predictor of treatment response in Generalized Anxiety Disorder. The study was sponsored by Inje University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Snippet

Sponsor: Inje University | Conditions: Generalized Anxiety Disorder | NA | Status: COMPLETED